In today’s market analysis, we turn our attention to three standout stocks that have recently caught the eye of analysts. These stocks have seen their price targets upgraded by individual analysts by more than 40%. Our focus today will be on Longboard Pharmaceuticals ( (LBPH) ), DHI Group ( (DHX) ), and Birkenstock Holding plc ( (BIRK) ).
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Longboard Pharmaceuticals
Longboard Pharmaceuticals (LBPH) is a clinical-stage biopharmaceutical company dedicated to developing innovative treatments for neurological diseases, particularly rare conditions. The company is advancing bexicaserin (LP352) for seizures associated with Developmental and Epileptic Encephalopathies (DEEs) and LP659 for rare neuroinflammatory conditions.
Analysts are optimistic about Longboard’s potential, with Cantor Fitzgerald’s Joshua Schimmer upgrading the stock’s price target from $60 to $90, reflecting a 50% increase and a 143% upside. Schimmer is a five-star analyst whose ratings on LBPH have yielded an average return of 122.75%.
Birkenstock Holding
Rooted in a tradition of quality and craftsmanship since 1774, Birkenstock is a global brand dedicated to promoting foot health through its iconic orthopedic footbeds. Its footwear is manufactured in Germany.
UBS analyst Jay Sole has raised the price target from $52 to $85, highlighting a promising 54% upside for the stock, reflecting confidence in Birkenstock’s enduring appeal and growth potential. Sole is a four-star analyst, according to TipRanks’ rankings.
DHI Group
DHI Group delivers specialized career marketplaces for tech roles through its brands, Dice and ClearanceJobs. These platforms enable efficient connections between recruiters and skilled technologists, particularly those with security clearances.
Analyst Eric Martinuzzi of Lake Street is optimistic about the stock’s future, raising the price target from $2.50 to $3.50, indicating a promising 62% upside. The analyst has confidence in DHI’s innovative approach and market position.
Conclusion
In summary, today’s analysis highlights three standout stocks—Longboard Pharmaceuticals (LBPH), Birkenstock Holding (BIRK), and DHI Group (DHX)—that have captured analysts’ attention with significant price target upgrades. With their promising upsides, these stocks represent exciting opportunities for investors.
As always, TipRanks is here to provide the latest news and insights on the stock market and analysts’ views, helping retail investors maximize their gains. To see more top analysts’ ratings, check out the TipRanks Analyst Top Stocks tool.
